Patent Right$

TitlePatent Right$
Publication TypeCase Study
Year of Publication2016
AuthorsSkipper, RB, Connolly, P, Althaus, RA, Malm, H
Date Published01/2016
PublisherAssociation for Practical and Professional Ethics
Publication Languageeng
AbstractA new drug to treat Hepatitis C, Sovaldi, costs $1000.00 a pill in the United States, and while effective, many insurance companies are unwilling to pay for this expensive treatment.  Some argue that the drug company who owns Sovaldi is charging too much, others argue that research, development, and clinical trials are expensive, and drug companies need to be able to profit from their efforts. 
NotesCase from the 2016 Intercollegiate Ethics Bowl National Championship.